Amphastar Pharmaceuticals, Inc. (29A.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:14AM CEST
| Previous Close | 39.10 |
| Open | 38.10 |
| Bid | 39.79 x 70000 |
| Ask | 40.34 x 70000 |
| Day's Range | 38.10 - 38.10 |
| 52 Week Range | 35.50 - 59.00 |
| Volume | |
| Avg. Volume | 4 |
| Market Cap | 1.958B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 14.22 |
| EPS (TTM) | 2.68 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.75 |
ACCESSWIREAmphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for ...
ZacksImplied Volatility Surging for Amphastar (AMPH) Stock Options
Investors need to pay close attention to Amphastar (AMPH) stock based on the movements in the options market lately.
- GuruFocus.com
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
© 2024 Yahoo. All rights reserved.